Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q4 2021 Earnings Presentation
7 slides from Aurora Cannabis's earnings presentation, Sep 21, 2021
Slide 1: Fiscal Q4 2021 Supplemental Information
Fiscal Q4 2021 Supplemental Information SEPTEMBER 2021
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Key Takeaways
3 Key Takeaways Medical Leadership #1 Canadian LP in Global Medical Cannabis Revenues Growing international medical segment with FY21 sales into 12 countries Vastly Improved Over $400 million of cash at June 30, 2021 All term debt paid off, and no convertible debt due for over 2 years Balanc
Slide 4: Q4 2021 Key Financial Highlights
4 Q4 2021 Key Financial Highlights • Strong Canadian Medical performance • #1 market share with strong and consistent margins Canadian Int’l Medical Adult Rec Consolidated Medical • Direct-to-patient model bypasses provincial distributor Net Revenue(1) • Consistency key driver of patient retention v
Slide 5: Key Financial Trends
5 Key Financial Trends Materially Reduced SG&A Materially Reduced Capital Investments Adj. SG&A (Including R&D) Expense (C$M) Capital Expenditures (C$M) 70 90 60 80 70 50 60 40 50 30 40 30 20 20 10 10 0 0 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Industry Leading Gross
Slide 6: Pathway to Positive Adjusted EBITDA
6 Pathway to Positive Adjusted EBITDA Cost savings map clear pathway to positive Adjusted EBITDA by mid FY23 without depending on revenue growth 60% Through Operational and $(14)M $15M - $20M Supply Chain Efficiencies FY21 Q4 Adjusted EBITDA(1) Quarterly Cash Savings(2) $7.5M - $10M within the next
Slide 7: Investor Relations
INVESTOR RELATIONS Email: aurora@icrinc.com Website: investor.auroramj.com